Several studies have proposed that an Hb decrease > 3 g/dL while undergoing transfusions is an accepted indication for angioembolization in different surgical conditions [11–14], but there are few studies which have focused on establishing quantified indications for SRAE in the setting of post-PCNL hemorrhage. Here, GSTM1 is linked to hemorrhage.